loadpatents
name:-0.030152797698975
name:-0.022109031677246
name:-0.0050959587097168
Johnson; Michael Ross Patent Filings

Johnson; Michael Ross

Patent Applications and Registrations

Patent applications and USPTO patent grants for Johnson; Michael Ross.The latest application filed is for "novel monothiol mucolytic agents".

Company Profile
5.26.32
  • Johnson; Michael Ross - Chapel Hill NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Monothiol mucolytic agents
Grant 10,968,233 - Johnson , et al. April 6, 2
2021-04-06
Prodrugs of dithiol mucolytic agents
Grant 10,526,283 - Johnson , et al. J
2020-01-07
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 10,526,292 - Johnson , et al. J
2020-01-07
Methods of treatment
Grant 10,335,558 - Boucher , et al.
2019-07-02
Novel Monothiol Mucolytic Agents
App 20190031679 - JOHNSON; Michael Ross ;   et al.
2019-01-31
Monothiol mucolytic agents
Grant 10,106,551 - Johnson , et al. October 23, 2
2018-10-23
Inhaled hypertonic saline delivered by a heated nasal cannula
Grant 9,987,443 - Boucher , et al. June 5, 2
2018-06-05
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20180111907 - Johnson; Michael Ross ;   et al.
2018-04-26
Sodium Channel Blockers For Skin Disorders
App 20180092915 - Johnson; Michael Ross ;   et al.
2018-04-05
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 9,878,988 - Johnson , et al. January 30, 2
2018-01-30
Sodium channel blockers for skin disorders
Grant 9,849,129 - Johnson , et al. December 26, 2
2017-12-26
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity
App 20170281620 - JOHNSON; Michael Ross
2017-10-05
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula
App 20170151396 - BOUCHER; Richard C. ;   et al.
2017-06-01
Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
Grant 9,655,896 - Johnson May 23, 2
2017-05-23
Sodium Channel Blockers For Skin Disorders
App 20170020870 - Johnson; Michael Ross ;   et al.
2017-01-26
Novel Prodrugs Of Dithiol Mucolytic Agents
App 20160318861 - JOHNSON; Michael Ross ;   et al.
2016-11-03
Inhaled hypertonic saline delivered by a heated nasal cannula
Grant 9,408,988 - Boucher , et al. August 9, 2
2016-08-09
Novel Monothiol Mucolytic Agents
App 20160222023 - JOHNSON; Michael Ross ;   et al.
2016-08-04
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20160122306 - JOHNSON; Michael Ross ;   et al.
2016-05-05
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 9,260,398 - Johnson , et al. February 16, 2
2016-02-16
Sodium Channel Blockers
App 20150376146 - JOHNSON; Michael Ross
2015-12-31
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity
App 20150290189 - JOHNSON; Michael Ross
2015-10-15
Chemically and metabolically stable dipeptide possessing potent sodium channel blocker activity
Grant 9,072,738 - Johnson July 7, 2
2015-07-07
Methods Of Treatment
App 20150101597 - BOUCHER; Richard C. ;   et al.
2015-04-16
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20150099764 - JOHNSON; Michael Ross ;   et al.
2015-04-09
Dendrimer like amino amides possessing sodium channel blocker activity for the treatment of dry eye and other mucosal diseases
Grant 8,980,898 - Johnson , et al. March 17, 2
2015-03-17
Methods of treatment
Grant 8,778,383 - Boucher , et al. July 15, 2
2014-07-15
Chemically And Metabolically Stable Dipeptide Possessing Potent Sodium Channel Blocker Activity
App 20140142118 - Johnson; Michael Ross
2014-05-22
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula
App 20140096765 - BOUCHER; Richard C. ;   et al.
2014-04-10
Poly Aromatic Sodium Channel Blockers
App 20140031371 - JOHNSON; Michael Ross
2014-01-30
Dendrimer Like Amino Amides Possessing Sodium Channel Blocker Activity For The Treatment Of Dry Eye And Other Mucosal Diseases
App 20130324559 - JOHNSON; Michael Ross ;   et al.
2013-12-05
Heteroaromatic pyrazinoylguanidine sodium channel blockers
Grant 8,575,176 - Johnson November 5, 2
2013-11-05
Inhaled hypertonic saline delivered by a heated nasal cannula
Grant 8,551,534 - Boucher , et al. October 8, 2
2013-10-08
Methods Of Treatment
App 20130074842 - Boucher; Richard C. ;   et al.
2013-03-28
Aliphatic Pyrazinoylguanidine Sodium Channel Blockers With Beta Agonist Activity
App 20130060034 - Johnson; Michael Ross
2013-03-07
Aliphatic pyrazinoylguanidine sodium channel blockers with beta agonist activity
Grant 8,324,218 - Johnson December 4, 2
2012-12-04
Methods of reducing risk of infection from pathogens
Grant 8,314,105 - Johnson November 20, 2
2012-11-20
Heteroaromatic Pyrazinoylguanidine Sodium Channel Blockers
App 20120116083 - JOHNSON; Michael Ross
2012-05-10
Phenyl substituted pyrazinoylguanidine sodium channel blockers possessing beta agonist activity
Grant 8,163,758 - Johnson , et al. April 24, 2
2012-04-24
Poly aromatic pyrazinoylguanidine sodium channel blockers
Grant 8,124,607 - Johnson February 28, 2
2012-02-28
Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
Grant 8,058,278 - Johnson , et al. November 15, 2
2011-11-15
Cyclic Substituted Pyrazinoylguanidine Sodium Channel Blockers Possessing Beta Agonist Activity
App 20110195973 - Johnson; Michael Ross
2011-08-11
Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes
Grant 7,981,898 - Johnson , et al. July 19, 2
2011-07-19
Phenyl Substituted Pyrazinoylguanidine Sodium Channel Blockers Possessing Beta Agonist Activity
App 20110008268 - Johnson; Michael Ross ;   et al.
2011-01-13
Aliphatic Pyrazinoylguanidine Sodium Channel Blockers With Beta Agonist Activity
App 20100267746 - Johnson; Michael Ross
2010-10-21
Poly Aromatic Sodium Channel Blockers
App 20090214444 - Johnson; Michael Ross
2009-08-27
Inhaled Hypertonic Saline Delivered By A Heated Nasal Cannula
App 20090104272 - BOUCHER; Richard C. ;   et al.
2009-04-23
Methods Of Enhancing Mucosal Hydration And Mucosal Clearance By Treatment With Sodium Channel Blockers And Osmolytes
App 20090082287 - Johnson; Michael Ross ;   et al.
2009-03-26
Methods Of Enhancing Mucosal Hydration And Mucosal Clearance By Treatment With Sodium Channel Blockers And Osmolytes
App 20080090841 - Johnson; Michael Ross ;   et al.
2008-04-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed